Items Tagged ‘refactory’

September 17th, 2015

Daratumumab Effective in Multiple Myeloma


The targeted agent, daratumumab, which is still in clinical trials, appears to be effective in patients with multiple myeloma that has stopped responding to standard therapies. These results were recently published in the New England Journal of Medicine. Multiple myeloma is a cancer of plasma cells, which are a special type of white blood cell […]

View full entry

Tags: clinical trial, daratumumab, Multiple Myeloma, News, Recurrent Multiple Myeloma, refactory